Article | May 8, 2020

Further Adapting New Bioprocess Technology In An Era Of Change

By K. John Morrow Jr., Ph.D.

Millipore Feature

Published with permission from Genetic Engineering & Biotechnology News (GEN)

Bioprocessing 4.0 (or Biopharma 4.0) is becoming more tangible every day; according to Darren Verlenden, head of bioprocessing at MilliporeSigma. He adds that the company has multiple initiatives and programs that are defining the application of Industry 4.0 principles for our products, technologies, and services. “The industry is at a convergence of digital and process technologies that offers significant value beyond incremental improvement within individual silos,” he said.

Verlenden described the digital environment as consisting of advanced automation platforms, interconnected bioprocessing systems, operators, and facilities, advanced data and process analytics, and finally, building bridges between end users, manufacturing sites, and suppliers.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of BioProcess Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: